Phase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Indolent LymphomaAggressive Lymphomas
VIDEO: First multicenter trial of CAR T cells shows response in DLBCLJanuary 19, 2017Aggressive Lymphomas
Antibody face-off in follicular lymphoma gives PFS, but not OS, edge to obinutuzumabDecember 5, 2016Indolent Lymphoma
Mogamulizumab achieves objective responses in relapsed/refractory adult T-cell leukemia-lymphomaJune 10, 2016Aggressive Lymphomas
Alemtuzumab plus CHOP didn’t boost survival in elderly patients with peripheral T-cell lymphomasJune 10, 2016Aggressive Lymphomas
